Fever in the ICU: A Predictor of Mortality in Mechanically Ventilated COVID-19 Patients.
COVID-19
ICU
coronavirus
critically ill
fever
hyperthermia
mortality
Journal
Journal of intensive care medicine
ISSN: 1525-1489
Titre abrégé: J Intensive Care Med
Pays: United States
ID NLM: 8610344
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
pubmed:
16
12
2020
medline:
16
3
2021
entrez:
15
12
2020
Statut:
ppublish
Résumé
While fever may be a presenting symptom of COVID-19, fever at hospital admission has not been identified as a predictor of mortality. However, hyperthermia during critical illness among ventilated COVID-19 patients in the ICU has not yet been studied. We sought to determine mortality predictors among ventilated COVID-19 ICU patients and we hypothesized that fever in the ICU is predictive of mortality. We conducted a retrospective cohort study of 103 ventilated COVID-19 patients admitted to the ICU between March 14 and May 27, 2020. Final follow-up was June 5, 2020. Patients discharged from the ICU or who died were included. Patients still admitted to the ICU at final follow-up were excluded. 103 patients were included, 40 survived and 63(61.1%) died. Deceased patients were older {66 years[IQR18] vs 62.5[IQR10], ( This is one of the first studies to identify ICU hyperthermia as predictive of mortality in ventilated COVID-19 patients. Additional predictors included male sex, age, and acidosis. With COVID-19 cases increasing, identification of ICU mortality predictors is crucial to improve risk stratification, resource management, and patient outcomes.
Identifiants
pubmed: 33317374
doi: 10.1177/0885066620979622
pmc: PMC7738811
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
484-493Références
J Infect. 2020 Oct;81(4):647-679
pubmed: 32417316
Am J Infect Control. 2021 Jan;49(1):82-89
pubmed: 32540370
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
JAMA. 2020 Apr 28;323(16):1612-1614
pubmed: 32191259
SAGE Open Med. 2020 Jun 03;8:2050312120928732
pubmed: 32547753
Crit Care. 2020 Jun 5;24(1):298
pubmed: 32503659
J Thorac Dis. 2015 Dec;7(12):E633-6
pubmed: 26793378
Chest. 2013 Oct;144(4):1098-1101
pubmed: 24081340
BMJ. 2020 May 22;369:m1966
pubmed: 32444366
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Lancet Respir Med. 2018 Mar;6(3):183-192
pubmed: 29325753
Crit Care Med. 2020 Sep;48(9):e799-e804
pubmed: 32452888
Crit Care Med. 2017 May;45(5):806-813
pubmed: 28221185
Clin Infect Dis. 2020 Nov 5;71(8):1962-1968
pubmed: 32472676
BMJ. 2020 Sep 9;370:m3339
pubmed: 32907855
Crit Care Resusc. 2018 Jun;20(2):150-163
pubmed: 29852854
Intensive Care Med. 2019 Apr;45(4):468-476
pubmed: 30741326
J Infect. 2020 Aug;81(2):e16-e25
pubmed: 32335169
Crit Care. 2020 May 14;24(1):219
pubmed: 32410714
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089
pubmed: 32396163
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
J Med Virol. 2020 Oct;92(10):1875-1883
pubmed: 32441789
PLoS One. 2012;7(1):e30077
pubmed: 22253887
BMJ. 2020 Apr 7;369:m1328
pubmed: 32265220
J Intern Med. 2020 Oct;288(4):469-476
pubmed: 32498135
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1560-1564
pubmed: 32348678
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Nat Rev Immunol. 2015 Jun;15(6):335-49
pubmed: 25976513
Shock. 2019 Aug;52(2):152-159
pubmed: 31058720
Intensive Care Med. 2015 May;41(5):823-32
pubmed: 25643903
Am J Respir Crit Care Med. 2012 May 15;185(10):1088-95
pubmed: 22366046